Stroke Summit Market Analysis and Reports | USA Conference Series

Market Analysis - Stroke Summit 2018

The Stroke Summit 2018 is a Two- Day program of presentations, panel discussions and interactive dialogue at the conference on leading the way in the research field of Cardiology, Neurology which is going to be held during August 31- September 01, 2018 at Boston, USA.

Theme: 

Exploring Insights in the prevention and treatment of Heart Failure, Brain Stroke and Neurological Disorders

Importance and Scope: 

Neurocardiology refers to the pathophysiological interactions between nervous and cardiovascular systems. It is an emerging field in medicine over the last decade. The constant communication between the heart and the brain have proved invaluable to interdisciplinary fields of neurological and cardiac diseases. The heart-brain’s neural circuitry enables it to act independently of the cranial brain to learn, remember, make decisions and even feel and sense. Persons with Heart Failure have higher incidence of Ischemic Stroke, varying from 1.7% to 10.4% per year. The stroke rate increases with length of follow-up. Reduced ejection fraction, independent of severity, is associated with higher risk of stroke.

Heart disease is the leading cause of death for both men and women. More than half of the deaths due to heart disease in 2008 were in men.  35.3% of deaths in American women over the age of 20, or more than 432,000, are caused by cardiovascular disease each year.

Why Boston?

Boston is the capital city and most populous municipality of the Commonwealth of Massachusetts in the United States. It is also the seat of Suffolk County, although the county government was disbanded on July 1, 1999.

The city covers 48 square miles with an estimated population of 673,184 in 2016 making it the largest city in the New England region of the northeastern United States. The city is the economic and cultural anchor of a substantially larger metropolitan area known as Greater Boston, a metropolitan statistical area home to a census-estimated 4.8 million people in 2016 and ranking as the tenth-largest such area in the country.

As a combined statistical area, this wider commuting region is home to some 8.2 million people, making it the sixth-largest in the United States.

Boston is one of the oldest cities in the United States, founded on the Shawmut Peninsula in 1630 by Puritan settlers from England. It was the scene of several key events of the American Revolution, such as the Boston Massacre, the Boston Tea Party, the Battle of Bunker Hill, and the Siege of Boston.

Upon U.S. independence from Great Britain, it continued to be an important port and manufacturing hub as well as a center for education and culture. The city has expanded beyond the original peninsula through land reclamation and municipal annexation.

Its rich history attracts many tourists, with Faneuil Hall alone drawing more than 20 million visitors per year. Boston's many firsts include the United States' first public school (Boston Latin School, 1635, first subway system and first public park.

The Boston area's many colleges and universities make it an international center of higher education, including law, medicine, engineering, and business and the city is a world leader in innovation and entrepreneurship, with nearly 2,000 start-ups.

Conference Highlights:

  • Heart Failure and Brain Health
  • Heart Diseases and Cardiac Arrest
  • Pediatric and Geriatric Cardiology
  • Cardiac Nursing and Health Care
  • Cardiovascular Research and Hypertension
  • Cardiac Surgery and Heart Regeneration
  • Stroke, Epidemiology, Management and Prevention
  • Paediatric Stroke and Recovery
  • Stroke Nursing and Interventions
  • Stroke Rehabilitation and Brain Haemorrhage
  • Alzheimer’s and Dementia
  • Neuroscience and Neuroimaging
  • Neurophysiology and Neurodegeneration
  • Neurological Disorders and Neuroplasticity
  • Clinical Trials in Neurology and Cardiology

Market Value for Cardiovascular Diseases Globally:

The cardiovascular disease market, which includes hypertension, dyslipidaemia and thrombotic events, is set to grow from $129.2 billion in 2015 to $146.4 billion by 2022, at a very modest compound annual growth rate of 1.8%.

Market Value for Cardiovascular Diseases in USA:

In 2010, coronary heart disease alone was projected to cost the United States $108.9 billion. This total includes the cost of health care services, medications, and lost productivity. Every year about 785,000 Americans have a first coronary attack. Another 470,000 who have already had one or more coronary attacks have another attack.

Market value of Stroke in UK

Stroke occurs approximately 152,000 times a year in the UK; that is stroke occurs every 3 minutes 27 seconds. First-time incidence of stroke occurs almost 17 million times a year worldwide. There are over 1.2 million stroke survivors in the UK. 3 in 10 stroke survivors will go on to have a recurrent stroke or TIA.1 in 8 strokes are fatal within the first 30 days.1 in 4 strokes are fatal within a year. Stroke is the fourth single largest cause of death in the UK and second in the world. By the age of 75, 1 in 5 women and 1 in 6 men will have a stroke.

Stroke kills twice as many women as breast cancer and more men than prostate and testicular cancer combined a year. Black people are twice as likely to have a stroke compared to white people. Black and South Asian people have strokes at a younger age compared to white people. Stroke is one of the largest causes of disability – half of all stroke survivors have a disability. Over a third of stroke survivors in the UK are dependent on others, of those 1 in 5 are cared for by family and/or friends. For every cancer patient living in the UK, £241 is spent each year on medical research, compared with just £48 a year for every stroke patient.

46,000 people in the UK have a first incidence of TIA every year. Approximately 15% of ischemic strokes are preceded by a TIA. The greatest risk of stroke is within the days immediately after a TIA.

USA Statistics of Stroke:

Stroke is the third leading cause of death in the United States. More than 140,000 people die each year from stroke in the United States. Stroke is the leading cause of serious, long-term disability in the United States. Each year, approximately 795,000 people suffer a stroke. About 600,000 of these are first attacks, and 185,000 are recurrent attacks.

Nearly three-quarters of all strokes occur in people over the age of 65. The risk of having a stroke more than doubles each decade after the age of 55. Strokes can and do occur at ANY age. Nearly one fourth of strokes occur in people under the age of 65. Stroke death rates are higher for African-Americans than for whites, even at younger ages.

On average, someone in the United States has a stroke every 40 seconds. Stroke accounted for about one of every 17 deaths in the United States in 2006. Stroke mortality for 2005 was 137,000. From 1995–2005, the stroke death rate fell ~30 percent and the actual number of stroke deaths declined ~14 percent.

Canadian Statistics of Stroke:

In 2000, stroke accounted for 7% of all deaths – 15,409 Canadians. Every seven minutes, a Canadian die of heart disease or stroke. Stroke was the second largest contributor to hospital care costs among cardiovascular diseases (2000-2001).

Eighty percent of Canadians have at least one of the risk factors for heart and/or cerebrovascular disease: daily smoking, physical inactivity, being overweight, self-reported high blood pressure, or diabetes. Between 1969 and 1999, death rates for cerebrovascular disease decreased by 62%.

Worldwide Statistics of Stroke:

According to the World Health Organization, 15 million people suffer stroke worldwide each year. Of these, 5 million dies and another 5 million are permanently disabled. High blood pressure contributes to more than 12.7 million strokes worldwide. Europe averages approximately 650,000 stroke deaths each year.

In developed countries, the incidence of stroke is declining, largely due to efforts to lower blood pressure and reduce smoking. However, the overall rate of stroke remains high due to the aging of the population.